Use of preclinical models to improve treatment of retinoblastoma

被引：43
|
作者：
Dyer, MA
Rodriguez-Galindo, C
Wilson, MW
机构：
[1] Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN
[2] Department of Hematology Oncology, St. Jude Children's Research Hospital, Memphis, TN
[3] Department of Surgery, Division of Ophthalmology, St. Jude Children's Research Hospital, Memphis, TN
[4] Department of Ophthalmology, University of Tennessee, Health Science Center, Memphis, TN
来源：
PLOS MEDICINE | 2005年 / 2卷 / 10期
关键词：
D O I：
10.1371/journal.pmed.0020332
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：971 / 976
页数：6
相关论文
共 50 条
  • [21] Use of preclinical models for malignant pleural mesothelioma
    Shamseddin, Marie
    Obacz, Joanna
    Garnett, Mathew J.
    Rintoul, Robert Campbell
    Francies, Hayley Elizabeth
    Marciniak, Stefan John
    THORAX, 2021, 76 (11) : 1154 - 1162
  • [22] PRECLINICAL DNA DIAGNOSIS IN HEREDITARY RETINOBLASTOMA
    HORSTHEMKE, B
    GREGER, V
    BARNERT, HJ
    HOPPING, W
    PASSARGE, E
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1987, 25 (09): : 569 - 569
  • [23] Preclinical results of sirolimus treatment in transplant models
    Stepkowski, SM
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (3A) : 219S - 226S
  • [24] Preclinical Models for Neuroblastoma: Establishing a Baseline for Treatment
    Teitz, Tal
    Stanke, Jennifer J.
    Federico, Sara
    Bradley, Cori L.
    Brennan, Rachel
    Zhang, Jiakun
    Johnson, Melissa D.
    Sedlacik, Jan
    Inoue, Madoka
    Zhang, Ziwei M.
    Frase, Sharon
    Rehg, Jerold E.
    Hillenbrand, Claudia M.
    Finkelstein, David
    Calabrese, Christopher
    Dyer, Michael A.
    Lahti, Jill M.
    PLOS ONE, 2011, 6 (04):
  • [25] Pharmacokinetic Analysis of Melphalan after Superselective Ophthalmic Artery Infusion in Preclinical Models and Retinoblastoma Patients
    Schaiquevich, Paula
    Buitrago, Emiliano
    Taich, Paula
    Torbidoni, Ana
    Ceciliano, Alejandro
    Fandino, Adriana
    Asprea, Marcelo
    Requejo, Flavio
    Abramson, David H.
    Bramuglia, Guillermo F.
    Chantada, Guillermo L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (07) : 4205 - 4212
  • [26] THE USE OF I-125 PLAQUES IN THE TREATMENT OF RETINOBLASTOMA
    STANNARD, C
    SEALY, R
    SHACKLETON, D
    HILL, J
    KORRUBEL, J
    OPHTHALMIC PAEDIATRICS AND GENETICS, 1987, 8 (02): : 89 - 93
  • [27] Immunotherapy for malignant glioma: preclinical models to improve efficacy of the immune attack
    Vandenberk, L.
    Verschuere, T.
    Vanhoven, K.
    KDks, C.
    De Vleeschouwer, S.
    Van Gool, S. W.
    KLINISCHE PADIATRIE, 2011, 223 (06): : 399 - 399
  • [28] Pheochromocytoma/paraganglioma preclinical models: which to use and why?
    Martinelli, Serena
    Maggi, Mario
    Rapizzi, Elena
    ENDOCRINE CONNECTIONS, 2020, 9 (12) : R251 - R260
  • [29] Retinoblastoma in transgenic mice: Models of hereditary retinoblastoma
    Mills, MD
    Windle, JJ
    Albert, DM
    SURVEY OF OPHTHALMOLOGY, 1999, 43 (06) : 508 - 518
  • [30] mTOR inhibition by TAK-228 is effective against growth, survival and angiogenesis in preclinical retinoblastoma models
    Tang, Lanlan
    Fu, Yu
    Song, Jiarun
    Hu, Taibing
    Li, Kun
    Li, Zhi
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2022, 10 (01):
12345